| Shannon Lea Miller, LCSW-C | |
|
711 Maiden Choice Ln, Catonsville, MD 21228-3632 | |
| (410) 247-5602 | |
| (410) 242-1756 |
| Full Name | Shannon Lea Miller |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 17 Years |
| Location | 711 Maiden Choice Ln, Catonsville, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922599984 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 15757 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Erickson Health Medical Group Of Maryland, Pc | 2860304136 | 36 |
| Erickson Health Medical Group Of Maryland, Pc | 2860304136 | 36 |
News Archive
EbolaScan.com launched today, bringing the power of local online alerts to U.S. residents concerned about new potential Ebola cases in their area. The free service, available via the web, tablets, and smartphones, alerts people with information about the latest reported cases nearby.
"Lesbian, Gay, Bisexual, and Transgender (LGBT) Aging: The Role of Gerontological Social Work", a special triple issue from the Journal of Gerontological Social Work is now available for FREE ACCESS all of September 2014.
Identifying one of the processes that plays a role in naïve and memory T-cells' growth and production could one day lead to better vaccines and possibly more effective cancer immunotherapy, said researchers at Baylor College of Medicine and Texas Children's Hospital in a report that appears in the current edition of Nature Immunology.
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $1.11 in the third quarter of fiscal 2011 after taking a charge for a new product licensing fee of $66.1 million or $0.23 per share, net of tax.
InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is Esbriet®.
› Verified 1 days ago
| Entity Name | Erickson Health Medical Group Of Maryland, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598816449 PECOS PAC ID: 2860304136 Enrollment ID: O20080528000404 |
News Archive
EbolaScan.com launched today, bringing the power of local online alerts to U.S. residents concerned about new potential Ebola cases in their area. The free service, available via the web, tablets, and smartphones, alerts people with information about the latest reported cases nearby.
"Lesbian, Gay, Bisexual, and Transgender (LGBT) Aging: The Role of Gerontological Social Work", a special triple issue from the Journal of Gerontological Social Work is now available for FREE ACCESS all of September 2014.
Identifying one of the processes that plays a role in naïve and memory T-cells' growth and production could one day lead to better vaccines and possibly more effective cancer immunotherapy, said researchers at Baylor College of Medicine and Texas Children's Hospital in a report that appears in the current edition of Nature Immunology.
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $1.11 in the third quarter of fiscal 2011 after taking a charge for a new product licensing fee of $66.1 million or $0.23 per share, net of tax.
InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is Esbriet®.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Lea Miller, LCSW-C 5730 Executive Dr Ste 230, Catonsville, MD 21228-1762 Ph: (410) 402-2379 | Shannon Lea Miller, LCSW-C 711 Maiden Choice Ln, Catonsville, MD 21228-3632 Ph: (410) 247-5602 |
News Archive
EbolaScan.com launched today, bringing the power of local online alerts to U.S. residents concerned about new potential Ebola cases in their area. The free service, available via the web, tablets, and smartphones, alerts people with information about the latest reported cases nearby.
"Lesbian, Gay, Bisexual, and Transgender (LGBT) Aging: The Role of Gerontological Social Work", a special triple issue from the Journal of Gerontological Social Work is now available for FREE ACCESS all of September 2014.
Identifying one of the processes that plays a role in naïve and memory T-cells' growth and production could one day lead to better vaccines and possibly more effective cancer immunotherapy, said researchers at Baylor College of Medicine and Texas Children's Hospital in a report that appears in the current edition of Nature Immunology.
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $1.11 in the third quarter of fiscal 2011 after taking a charge for a new product licensing fee of $66.1 million or $0.23 per share, net of tax.
InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is Esbriet®.
› Verified 1 days ago
Ms. Joyce Ann Mccauley, MSW LCSWC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2 W Rolling Crossroads, Catonsville, MD 21228 Phone: 410-719-0086 Fax: 410-744-2321 | |
Mr. Joseph Zappala, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 508 Frederick Rd, Catonsville, MD 21228 Phone: 240-645-8575 | |
Barbara Ellen Lazar, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 606 Marianne Ln, Catonsville, MD 21228 Phone: 410-750-1245 | |
Kathleen Kern, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 516 N Rolling Rd Ste 305, Catonsville, MD 21228 Phone: 410-572-7981 | |
Rebecca Statman, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 500 Wade Ave, Treatment Research Unit - Tawes A, Catonsville, MD 21228 Phone: 410-402-6875 | |
Ms. Jennifer Katzen Mansir, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 324 Greenlow Rd, Catonsville, MD 21228 Phone: 443-851-0366 | |
Lawrence S Yurow, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 5602 Baltimore National Pike, Suburbia Building. Suite 506, Catonsville, MD 21228 Phone: 410-744-9100 Fax: 410-747-0226 |